Pfizer Newsroom

Leerink Partners Maintains Pfizer(PFE.US) With Hold Rating

Futu NewsNov 21 02:31

BioNTech Stock Has Been Hit Hard Since RFK Jr.'s Nomination. Why This Analyst Upgraded It. -- Barrons.com

Barron'sNov 20 00:57

Wolfe Research Initiates Pfizer at Underperform With $25 Price Target

MT NewswiresNov 15 19:05

Pfizer Analyst Ratings

BenzingaNov 15 18:57

Wolfe Research Downgrades Pfizer(PFE.US) to Sell Rating, Announces Target Price $25

Futu NewsNov 15 05:30

UBS Maintains Pfizer(PFE.US) With Hold Rating, Maintains Target Price $31

Futu NewsNov 14 20:35

UBS Remains a Hold on Pfizer (PFE)

TipRanksNov 14 19:38

CFRA Upgrades Pfizer(PFE.US) to Buy Rating, Cuts Target Price to $30

Futu NewsNov 13 15:31

Jefferies Maintains Pfizer(PFE.US) With Buy Rating, Maintains Target Price $33

Futu NewsNov 12 21:33

Jefferies Remains a Buy on Pfizer (PFE)

TipRanksNov 12 21:10

Daiwa Securities Adjusts Pfizer's Price Target to $28 From $34, Keeps Outperform Rating

MT NewswiresNov 6 18:24

Pfizer's Ponsegromab: A Promising Yet Uncertain Opportunity Influencing Hold Rating

TipRanksNov 5 13:42

Evercore Maintains Pfizer(PFE.US) With Buy Rating

Futu NewsNov 4 21:31

Truist Financial Maintains Pfizer(PFE.US) With Buy Rating

Futu NewsNov 4 20:35

Barclays Maintains Pfizer(PFE.US) With Hold Rating, Maintains Target Price $32

Futu NewsNov 4 17:33

UBS Maintains Pfizer(PFE.US) With Hold Rating, Raises Target Price to $31

Futu NewsNov 2 04:31

A Quick Look at Today's Ratings for Pfizer(PFE.US), With a Forecast Between $31 to $33

Futu NewsOct 31 21:20

A Quick Look at Today's Ratings for Pfizer(PFE.US), With a Forecast Between $30 to $36

Futu NewsOct 30 21:12

Leerink Partners Maintains Pfizer(PFE.US) With Hold Rating

Futu NewsOct 29 20:33

Pfizer Analyst Ratings

BenzingaOct 25 23:55